The Pharmacy and Poisons Board of Kenya on Saturday, January 18 issued new orders on pharmaceutical products entering the Kenyan market that reference the Indian pharmacopoeia (IP).
Through a statement, the Board raised alarm on an influx of unregistered pharmaceutical products into Kenya.
According to the Board, most of these drugs are referencing Indian pharmacopeia, which is an Indian method of drug standardization. The Indian Pharmacopoeia is a set of standards for all drugs that are sold, manufactured, and consumed in India.
The Board, whose mandate is to protect the health of the public through regulation, noted that IP standardisation does not fall in line with Kenya's range of pharmaceutical registration requirements.
